All Publications | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Displaying 2 results.

- Journal article
The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
Bousser, M G Amarenco, P Chamorro, A Fisher, M Ford, I Fox, K Hennerici, M Mattle, H P Rothwell, P M Peeters, André[UCL] (2009) Cerebrovascular Diseases — Vol. 27, no.6, p. 608-13 (2009)
- Journal article
Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Bousser, M G Amarenco, P Chamorro, A Fisher, M Ford, I Fox, K Hennerici, M G Mattle, H P Rothwell, P M Peeters, André[UCL] Laloux, Patrice[UCL] (2009) Cerebrovascular Diseases — Vol. 27, no.5, p. 509-18 (2009)